ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · IEX Real-Time Price · USD
1.89
+0.04 (2.16%)
At close: Jun 2, 2023, 4:00 PM
1.91
+0.02 (1.06%)
After-hours: Jun 2, 2023, 5:24 PM EDT

ProQR Therapeutics Stock Forecast

Stock Price Forecast

According to 4 stock analysts, the average 12-month stock price forecast for PRQR stock stock is $5.13, which predicts an increase of 171.43%. The lowest target is 4.50 and the highest is 6.00. On average, analysts rate PRQR stock stock as a buy.

Analyst Consensus: Buy
Target Low Average Median High
Price $4.50 $5.13 $5.00 $6.00
Change +138.10% +171.43% +164.55% +217.46%

Analyst Ratings

The average analyst rating for PRQR stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '22Jan '23Feb '23Mar '23Apr '23May '23
Strong Buy 111111
Buy 333333
Hold 111111
Sell 000000
Strong Sell 000000
Total 555555

Financial Forecast

Revenue This Year
29.01M
from 4.80M
Increased by 504.14%
Revenue Next Year
12.82M
from 29.01M
Decreased by -55.81%
EPS This Year
-0.34
from -0.91
EPS Next Year
-0.45
from -0.34
Year 2018201920202021202220232024202520262027
Revenue
5.76M1.93M9.45M2.40M4.80M29.01M12.82M17.23M8.31M7.52M
Revenue Growth
285.35%
-66.45%
388.98%
-74.64%
100.33%
504.14%
-55.81%
34.43%
-51.80%
-9.52%
EPS
-1.08-1.38-0.93-0.96-0.91-0.34-0.45-0.36--
EPS Growth
----------
No. Analysts -----97755
Financial currency is EUR

Revenue Forecast

Revenue 20232024202520262027
High 66.4M 28.8M 44.5M 16.2M 12.8M
Avg 29.0M 12.8M 17.2M 8.3M 7.5M
Low n/a 4.9M 2.0M 1.9M 1.9M

Revenue Growth

Revenue Growth 20232024202520262027
High
1,282.5%
-0.8%
247.4%
-6.0%
54.2%
Avg
504.1%
-55.8%
34.4%
-51.8%
-9.5%
Low -
-83.1%
-84.7%
-89.1%
-77.3%

EPS Forecast

EPS 202320242025
High 0.34 -0.28 -0.12
Avg -0.34 -0.45 -0.36
Low -0.57 -0.64 -0.74

EPS Growth

EPS Growth 202320242025
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.